Purple Biotech Ltd (TLV:PPBT)
Israel
· Delayed Price · Currency is ILS · Price in ILA 1.000
0.00 (0.00%)
At close: Mar 6, 2026
Purple Biotech Employees
Purple Biotech had 9 employees as of December 31, 2024. The number of employees decreased by 11 or -55.00% compared to the previous year.
Employees
9
Change (1Y)
-11
Growth (1Y)
-55.00%
Revenue / Employee
n/a
Profits / Employee
-1.20M ILS
Market Cap
18.58M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Can-Fite BioPharma | 5 |
| XTL Biopharmaceuticals | 10 |
| Evogene | 117 |
| BioLight Life Sciences | 4 |
| BioLineRx | 28 |
| Matricelf | 12 |
| Bonus BioGroup | 37 |
Purple Biotech News
- 3 months ago - Purple Biotech to Present New Preclinical Data from its CAPTN-3 Tri-Specific Antibody Platform at the European Society of Medical Oncology Immuno-Oncology (ESMO-IO) 2025 Annual Congress - GlobeNewsWire
- 4 months ago - Purple Biotech Reports Third Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 4 months ago - Purple Biotech Achieves Manufacturing Milestone for IM1240, a Tri-Specific Antibody from the CAPTN-3 Platform - GlobeNewsWire
- 5 months ago - Purple Biotech Announces Receipt of Nasdaq Minimum Bid Price Notification - GlobeNewsWire
- 6 months ago - Purple Biotech Announces Closing of Up To $18 Million Public Offering $6 million upfront with up to an additional $12 million of potential aggregate gross proceeds upon the exercise in full of short-term warrants - GlobeNewsWire
- 6 months ago - Purple Biotech to Participate in the H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire
- 7 months ago - Purple Biotech Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 8 months ago - Purple Biotech CEO Issues Letter to Shareholders Highlighting Pipeline Progress and Clinical Milestones Achieved in First Half of 2025 - GlobeNewsWire